University of Arkansas for Medical Sciences (UAMS)
Welcome,         Profile    Billing    Logout  
 15 Trials 
29 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wolfe, Robert R
SUVN-G3031, NCT04072380: A Study to Evaluate Safety, and Efficacy of (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

Completed
2
190
Canada, US
SUVN-G3031, Samelisant, Placebo
Suven Life Sciences Limited
Narcolepsy
06/23
06/23
EAAPD, NCT06604065: Essential Amino Acids and Parkinsons Disease

Not yet recruiting
1
15
NA
AMS2434 (amino acids), Amino Acids, Placebo
University of Arkansas
Parkinson Disease
06/26
12/26
NCT05066503: Nutritional Therapy for Delirium in Elderly Hospitalized Subjects

Suspended
N/A
45
US
260279 active study product, there is not a non-proprietary name for this supplement.
University of Arkansas
Subacute Delirium
01/26
08/26
NCT05714462: Effects of Beef Consumption on Skeletal Muscle Protein Homeostasis and Inflammatory Factors in Pre- and Postmenopausal Females

Recruiting
N/A
90
NA
meals consisting of primarily animal protein sources, meals consisting of plant protein sources
University of Arkansas
Menopause Related Conditions
01/25
01/25
Ryan, Elizabeth
STOP360AG, NCT05548283: Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

Recruiting
4
730
Canada, US
Beta-lactam antibiotic, β-lactam, Aminoglycoside, AG
Chris Goss, University of Washington, Medical University of South Carolina, Cystic Fibrosis Foundation
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation
11/26
11/26
NCT06016088: A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Recruiting
1/2
72
US, RoW
RSP-1502, Tobramycin inhalation solution
Respirion Pharmaceuticals Pty Ltd
Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa
12/25
12/25
NCT01182506: Rehabilitation of Cognitive Changes in Breast Cancer Survivors

Active, not recruiting
N/A
60
US
Cogmed Working Memory Training Program
Memorial Sloan Kettering Cancer Center, MARTELL FOUNDATION
Breast Cancer
08/25
08/25
NCT06504589: A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Recruiting
N/A
400
US
Nicole Hamblett, Washington University School of Medicine, Florida State University, University of North Carolina, Chapel Hill, University of Toronto, Cystic Fibrosis Foundation
Cystic Fibrosis
08/29
08/29
STOP PEDS RCT, NCT06654752: Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

Recruiting
N/A
430
Canada, US
Immediate Oral Antibiotics, Tailored Treatment: Oral Antibiotics only if Additional Treatment needed
University of Washington, the Collaborative Health Studies Coordinating Center, Cystic Fibrosis Foundation
Cystic Fibrosis
12/27
02/29
NCT05639556: Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF

Recruiting
N/A
300
US
BMI and lean mass index from DXA, Anthropometric Measurements, Hand-grip strength, Six-minute walk Test, Sit-to-Stand Test, Short physical performance battery (SPPB), BIA Sub-study, Accelerometry to assess physical activity, Gastrointestinal (GI) and nutrition questionnaires:, Psychosocial questionnaire: PHQ-8, Psychosocial questionnaire: GAD-7, Psychosocial questionnaire: The Treatment Self-Regulation Questionnaire (TSRQ), Psychosocial questionnaire: CF Fatalism Scale, Psychosocial questionnaire: Body Esteem Scale for Adolescents and Adults (BESAA), 12-month Questionnaire, Oral glucose tolerance testing (OGTT), Continuous glucose monitoring (CGM), Chest CT scans (When available within the past 6 months in medical records), Hologic Dual X-Ray Absorptiometry (DXA), Ultrasound Sub-study of assessment of appendage muscles using ultrasound, Psychosocial questionnaire: Hunger Vital Sign questionnaire, Respiratory symptom questionnaire: CRISS, Spirometry, Psychosocial questionnaire: Additional Health Questionnaire
Jaeb Center for Health Research
Cystic Fibrosis
12/28
12/28
Neuman, Mark D
THRIVE, NCT05346588: Feasibility Trial

Completed
3
300
US
Anesthetic technique Propofol TIVA, Propofol TIVA, Anesthetic technique inhaled agent, Inhaled agent
Washington University School of Medicine, University of Michigan, University of Pennsylvania, Stanford University, Patient-Centered Outcomes Research Institute
Surgery--Complications, Anesthesia Complication, Anesthesia Awareness, Anesthesia Emergence Delirium, Anesthesia, Surgery, Quality of Life, Pain, Postoperative, Nausea, Postoperative, Anesthesia Morbidity, Depression, Sleep Disorders, Circadian Rhythm
04/23
06/23
REGAIN, NCT02507505: Regional Versus General Anesthesia for Promoting Independence After Hip Fracture

Completed
N/A
1848
Canada, US
Regional Anesthesia, Regional Block or Spinal Block, General Anesthesia, General Endotracheal Anesthesia
University of Pennsylvania, Patient-Centered Outcomes Research Institute
Hip Fractures
06/21
03/22
DROP-Benzo, NCT05436392: De-adopting Routine Preoperative Benzodiazepines for Older Surgical Patients

Completed
N/A
517611
US
Peer Comparison Feedback, Patient Informational Letter
University of Pennsylvania, US Anesthesia Partners, Donaghue Medical Research Foundation
Surgery, Aging
06/23
12/23
NCT06438640: Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)

Recruiting
N/A
3548
US
My Anesthesia Choice-HF Model
University of Pennsylvania, Wake Forest University Health Sciences, University of Florida, Dartmouth-Hitchcock Medical Center, Henry Ford Health System, The Cleveland Clinic, Dartmouth College, Washington University School of Medicine
Hip Fractures, Femoral Neck Fractures, Intertrochanteric Fractures, Subtrochanteric Fractures
05/27
05/28
THRIVE, NCT05991453: Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

Recruiting
N/A
12500
US
Anesthetic technique Propofol TIVA, Propofol TIVA, Anesthetic technique inhaled agent, Inhaled agent
Washington University School of Medicine, Patient-Centered Outcomes Research Institute, University of Michigan
Surgery-Complications, Anesthesia Complication, Anesthesia Awareness, Anesthesia, Surgery, Quality of Life, Pain, Postoperative, Anesthesia Morbidity
07/27
07/28
Ong, Shirley
ACTION, NCT05580562: ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the Study)

Calendar Jan 2026 - Dec 2026: Final data from ACTION trial for newly diagnosed H3 K27M-mutant diffuse glioma
Calendar Jan 2025 - Mar 2025: Interim data from ACTION trial for newly diagnosed H3 K27M-mutant diffuse glioma
Recruiting
3
450
Europe, Canada, Japan, US, RoW
Dordaviprone (ONC201), Dordaviprone (ONC201) + Placebo, Placebo
Chimerix
H3 K27M, Glioma
08/26
08/26
NRG-BN011, NCT05095376: Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine®) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Recruiting
3
306
Canada, US
Lomustine, 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea, 1-Nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-, Belustin, Belustine, CCNU, Cecenu, CeeNU, Chloroethylcyclohexylnitrosourea, Citostal, Gleostine, Lomeblastin, Lomustinum, Lucostin, Lucostine, N-(2-Chloroethyl)-N'-cyclohexyl-N-nitrosourea, Prava, RB-1509, WR-139017, Photon Beam Radiation Therapy, Photon EBRT, Photon External Beam Radiotherapy, Radiation, Photon Beam, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Temozolomide, CCRG-81045, Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-, M & B 39831, M and B 39831, Methazolastone, RP-46161, SCH 52365, Temcad, Temodal, Temodar, Temomedac, TMZ
NRG Oncology, National Cancer Institute (NCI)
Glioblastoma, Gliosarcoma
08/26
08/31
NCT04145115: A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden

Suspended
2
37
US
Ipilimumab, Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody, BMS 734016, BMS-734016, BMS734016, Ipilimumab Biosimilar CS1002, MDX 010, MDX-010, MDX-CTLA4, MDX010, Yervoy, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Nivolumab, ABP 206, BCD-263, BMS 936558, BMS-936558, BMS936558, CMAB819, MDX 1106, MDX-1106, MDX1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO 4538, ONO-4538, ONO4538, Opdivo
National Cancer Institute (NCI)
Astrocytoma, IDH-Mutant, Grade 4, Diffuse Glioma, Glioblastoma, IDH-Wildtype, Secondary Glioblastoma
05/25
05/25
NCT04762069 / 2021-003659-40: A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

Hourglass Jan 2023 - Jun 2023 : Data from trial for glioblastoma
Hourglass Jul 2022 - Dec 2022 : Interim analysis data from trial for glioblastoma in adults
Active, not recruiting
2
210
Europe, US
Berubicin, Berubicin Hydrochloride, Lomustine, Lomustine Capsules, CCNU, CeeNU, Gleostine
CNS Pharmaceuticals, Inc., Worldwide Clinical Trials
Glioblastoma Multiforme, Adult
12/24
03/25
ReSPECT-LM, NCT05034497: Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases

Recruiting
1
18
US
186RNL, Rhenium-186 NanoLiposome
Plus Therapeutics
Leptomeningeal Metastasis
12/25
06/26
DCVax-L EAP, NCT02146066: Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221

Available
N/A
US
DCVax-L
Northwest Biotherapeutics
GBM, Glioblastoma Multiforme
 
 
Johnson, Larry G
BMX-04-001, NCT05010577 / 2022-003810-35: Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

Active, not recruiting
1b/2a
32
Europe, US, RoW
BX004-A, Bacteriophage, Placebo, Vehicle buffer
BiomX, Inc., BiomX Ltd.
Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis
10/23
03/24
NCT06052293: Phase 1 Study to Assess Safety and Efficacy of ANG003

Completed
1
51
US
ANG003, Dose Level 1, Dose Level 2, Dose Level 3, and Dose Level 4.
Anagram Therapeutics, Inc.
Exocrine Pancreatic Insufficiency
07/24
07/24
NCT05639556: Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF

Recruiting
N/A
300
US
BMI and lean mass index from DXA, Anthropometric Measurements, Hand-grip strength, Six-minute walk Test, Sit-to-Stand Test, Short physical performance battery (SPPB), BIA Sub-study, Accelerometry to assess physical activity, Gastrointestinal (GI) and nutrition questionnaires:, Psychosocial questionnaire: PHQ-8, Psychosocial questionnaire: GAD-7, Psychosocial questionnaire: The Treatment Self-Regulation Questionnaire (TSRQ), Psychosocial questionnaire: CF Fatalism Scale, Psychosocial questionnaire: Body Esteem Scale for Adolescents and Adults (BESAA), 12-month Questionnaire, Oral glucose tolerance testing (OGTT), Continuous glucose monitoring (CGM), Chest CT scans (When available within the past 6 months in medical records), Hologic Dual X-Ray Absorptiometry (DXA), Ultrasound Sub-study of assessment of appendage muscles using ultrasound, Psychosocial questionnaire: Hunger Vital Sign questionnaire, Respiratory symptom questionnaire: CRISS, Spirometry, Psychosocial questionnaire: Additional Health Questionnaire
Jaeb Center for Health Research
Cystic Fibrosis
12/28
12/28
Petersen, Erika
VISION, NCT05774041: Visualization of the STN and GPi for DBS

Recruiting
N/A
90
US
SIS System
Surgical Information Sciences Inc.
Deep Brain Stimulation, Parkinson Disease
02/25
08/25
NCT04246281: The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain

Active, not recruiting
N/A
230
US
SPRINT Peripheral Nerve Stimulation (PNS) System, Standard interventional management of low back pain
SPR Therapeutics, Inc., United States Department of Defense
Low Back Pain, Back Pain
03/26
02/27
Witkowski, Cindy
WARRIOR, NCT03417388: Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

Active, not recruiting
4
2476
US
High dose potent statin, atorvastatin or rosuvastatin, ACE-I (lisinopril) or ARB (losartan), ACE-I or ARB, Aspirin, Lifestyle Counseling, PACE Lifestyle Intervention, Quality of Life Questionnaires, QOL
University of Florida, United States Department of Defense
Coronary Artery Disease
02/25
09/25
Keyes, Alperdis L
SARCA, NCT05339139: SAfety of Regional Citrate Anticoagulation ( Study)

Recruiting
3
50
US
Dialysis
Fresenius Medical Care North America
Acute Kidney Injury, ESRD
11/24
03/25
Muller, Geoffrey
THRIVE, NCT05991453: Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

Recruiting
N/A
12500
US
Anesthetic technique Propofol TIVA, Propofol TIVA, Anesthetic technique inhaled agent, Inhaled agent
Washington University School of Medicine, Patient-Centered Outcomes Research Institute, University of Michigan
Surgery-Complications, Anesthesia Complication, Anesthesia Awareness, Anesthesia, Surgery, Quality of Life, Pain, Postoperative, Anesthesia Morbidity
07/27
07/28

Download Options